Autor(es): Dias, Alexandre ; Silva, Isabel ; Pinto, Inês Mendes ; Maia, Luis
Data: 2021
Identificador Persistente: http://hdl.handle.net/10400.16/2905
Origem: Repositório Científico da Unidade Local de Saúde de Santo António (ULSSA)
Assunto(s): POC devices; biomarkers; biosensors; blood; stroke
Stroke is a leading cause of death and disability in the world. To address such a problem, early diagnosis and tailored acute treatment represent one of the major priorities in acute stroke care. Since the efficacy of reperfusion treatments is highly time-dependent, there is a critical need to optimize procedures for faster and more precise diagnosis. We provide a concise review of the most relevant and well-documented blood-protein biomarkers that exhibit greater potential for translational to clinical practice in stroke differential diagnosis and to differentiate ischemic stroke from hemorrhagic stroke, followed by an overview of the most recent point-of-care technological approaches to address this problem. The integration of fluid-based biomarker profiling, using point-of-care biosensors with demographic, clinical, and neuroimaging parameters in multi-dimensional clinical decision-making algorithms, will be the next step in personalized stroke care.
